Clinical Trials Browser

Phase 2 × Sorafenib × Breast × Clear all

NCT05594095 2024-10-04

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT00096434 2024-03-07

Sorafenib in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00622466 2020-10-19

Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Phase 2 Terminated

20 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00499525 2019-05-03

Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Breast Neoplasms, Male

NCT00722072 2018-02-26

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Phase 2 Terminated

12 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00632541 2018-02-14

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Phase 2 Terminated

18 enrolled 11 charts

Breast Neoplasms

NCT01320111 2017-02-20

PASO

Phase 2 Completed

Breast Neoplasms

NCT01194869 2016-10-18

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Phase 2 Terminated

25 enrolled 8 charts

Breast Neoplasms

NCT00548899 2015-03-09

SOFIA

Phase 2 Completed

Breast Neoplasms

NCT00525161 2015-01-26

Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

Phase 2 Terminated

11 enrolled 20 charts

Breast Neoplasms

NCT00493636 2014-05-20

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Phase 2 Completed

160 enrolled 11 charts

Breast Neoplasms

NCT00101400 2013-12-13

BAY43-9006 - Phase II in Advanced Breast Cancer

Phase 2 Completed

54 enrolled 13 charts

Breast Neoplasms, Neoplasms

NCT00607438 2012-05-11

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis